Robert C. Green MD, MPH

Robert C. Green is a Professor of Medicine at Harvard Medical School, a medical geneticist and physician-scientist who directs the Genomes2People Research Program at Brigham and Women’s Hospital, the Broad Institute, and Harvard Medical School. Dr. Green conducts research to accelerate the evidence-based implementation of genomic medicine.

Dr. Green led the first experimental trials disclosing common complex disease risk (REVEAL Study) and the first prospective studies of direct-to-consumer genetic testing services (PGen Study). He currently leads the first randomized trials to explore the implementation of medical sequencing in adults (MedSeq Project) and newborns (BabySeq Project). He has published over 300 scientific papers and in 2014, won the Coriell Prize for Scientific Achievement in Personalized Medicine.

Dr. Green was the lead author on the initial recommendations for managing incidental findings in clinical sequencing from the American College of Medical Genetics and Genomics and a co-author on recommendations for managing incidental findings in research biobanks among participants and among family members of participants. He is a member of the National Academies of Science, Engineering, and Medicine Committee on the “Evidence Base for Genetic Testing” and a Board Member of the Council for Responsible Genetics.

Keynote and plenary presentations include the American College of Medical Genetics and Genomics, Cold Spring Harbor, World Congress of Psychiatric Genetics, Human Genome Variation Society, European Society for Human Genetics, BioData World, Forbes Healthcare Summit, World Science Festival, Future of Genomic Medicine Conference, Exponential Medicine Conference and Festival of Genomics.

His work and commentary have been featured on PBS television documentaries, and repeatedly highlighted on PBS radio, NBC Nightly News, the Today Show, CNBC, the New York Times, the Wall Street Journal, Time Magazine, New Scientist, FastCompany, GenomeWeb and Buzzfeed.